Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02534168 · ClinicalTrials.gov registry record
Post-surgical Pain Assessment in Children: Roles of Skin Conductance and Genomics
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 162
- Enrollment target
NCT02534168: Clinical Trial study, sponsored by Milton S. Hershey Medical Center.
NCT02534168 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 162 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02534168 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 162 participants
- Enrollment target
Study Summary
Pain assessment in infants and toddlers is quite challenging since children in these populations are nonverbal or preverbal and cannot describe the presence and severity of pain that they perceive. Over the last decade, advances in the field have included the development of behavioral scoring systems for the assessment of acute pain . However, although they have been validated, these commonly used methods of pain assessment are largely subjective and rely on a highly trained observer. An objective continuous measure of pain would be an important addition to standard behavioral pain scores which require nurses to monitor the child's behavioral responses.
Primary Outcome
The skin conductance monitor will be attached to the patient in the Post-Anesthesia Care Unit (PACU) for 1 hour and the skin conductance values will be analyzed off-line. Corresponding pain scores on a scale of 0-10 using the FLACC (Face, Legs, Activity, Cry and Consolability) scale will be noted every 5 minutes for a period of 1 hour. The skin conductance values will be measured in microsiemens, also the frequency of the skin conductance responses per second will be measured. The ability of ski
Interventions
- DEVICE Skin conductance monitor for measuring skin conductance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2015-11-16 |
| Est. Completion | 2020-08-12 |
Why NCT02534168 stopped before completion
NCT02534168 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Skin conductance monitor for measuring skin conductance is the first listed.
NCT02534168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02534168 about?
NCT02534168 is a clinical study titled "Post-surgical Pain Assessment in Children: Roles of Skin Conductance and Genomics". Pain assessment in infants and toddlers is quite challenging since children in these populations are nonverbal or preverbal and cannot describe the presence and severity of pain that they perceive. Over the last decade, advances in the field have included the development of behavioral scoring system...
What is the current status of trial NCT02534168?
This trial is currently terminated. The enrollment target is 162 participants. The study started on 2015-11-16. Estimated completion is 2020-08-12.
What interventions are being tested in trial NCT02534168?
The interventions under investigation include: Skin conductance monitor for measuring skin conductance (DEVICE).
Who is sponsoring clinical trial NCT02534168?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI